The possibility of idioperipheral pulsation in calves with chronic nonpulsatile biventricular bypass has been previously reported. To test the hypothesis that both spontaneous respiration and mechanical ventilation are the cause of pulsation in the arterial pressure recording in calves with nonpulsatile biventricular bypass, two protocols were used to generate data. Both right and left ventricles were bypassed using two centrifugal pumps followed by electrical fibrillation in seven calves. In protocol 1, the spontaneous respiratory rate was increased in awake calves by carbon dioxide gas inhalation. In protocol 2, the animals were anesthetized and intubated to control ventilation, and data were collected as the ventilation rate or tidal volume was changed in a stepwise fashion, as well as when the ventilation was stopped for several seconds. The results of protocol 1 showed good correlation between the arterial pulse rate and spontaneous respiratory rate (Y = 1.03 X, r = 0.822, p < 0.001). The results of protocol 2 showed that the relationship between the ventilation rate and the arterial pulse cycle was identical (Y = X, r = 1.000, p < 0.001), and no pulsation was seen when the ventilator was stopped. The authors conclude that the arterial pulsation observed in calves with nonpulsatile biventricular bypass is caused by respiration.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
In silico Prediction of Thrombosis Risk in a Ventricular Assist Device Supported Right Heart: The Impact of Cannulation Site.
ASAIO J
October 2022
From the Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, Victoria, Australia.
Right ventricular assist device (RVAD) associated thrombosis is a serious complication that may arise due to unfavorable blood flow dynamics (blood stasis) caused by RVAD cannula protrusion within the chambers. This study aims to investigate the thrombosis risk of cannulation via the right atrium (RA) and right ventricle (RV) (diaphragmatic) under full RVAD support using computational fluid dynamics. A HeartWare HVAD inflow cannula was virtually implanted in either the RA or RV of a rigid-walled right heart geometry (including RA, RV, superior, and inferior vena cava) extracted from computed tomography data of a biventricular support patient.
View Article and Find Full Text PDFCase report of the broad spectrum of late complications in an adult patient with univentricular physiology palliated by the Fontan circulation.
Eur Heart J Case Rep
February 2022
CAHAL, Center for Congenital Heart Disease Amsterdam Leiden, Leiden University Medical Center, Leiden, the Netherlands.
Article Synopsis
- * The Fontan procedure connects the inferior vena cava to the pulmonary circulation, allowing passive blood flow without a functional second ventricle, which leads to long-term health challenges for patients.
- * A multidisciplinary team approach is essential for monitoring and managing these patients post-surgery, in order to detect complications early and enhance their quality of life.
Feasibility of long-term continuous flow total heart replacement in calves.
Int J Artif Organs
January 2022
Cardiovascular Surgical Research Laboratory, Texas Heart Institute, Houston, TX, USA.
Introduction: Implementation of continuous flow (CF) technology in modern ventricular assist devices (VAD) has afforded a wealth of engineering and design advantages in the development of a total artificial heart (TAH). However, clinical application of CF has created a unique physiologic state, the consequences of which remain largely unknown. We sought to evaluate clinical and biochemical markers of end-organ function in calves supported with biventricular CF VADs for more than 30 days.
View Article and Find Full Text PDFExperience in anaesthetic management of non-cardiac surgery in patients with ventricular assist devices.
Rev Esp Anestesiol Reanim (Engl Ed)
January 2019
Servicio de Anestesia y Reanimación, Hospital Puerta de Hierro, Majadahonda, Madrid, España.
Heart failure (HF) is a syndromic condition with a high incidence in current medicine. When the symptoms of HF progress, and become refractory, cardiac transplant is the best therapeutic option. However, due to the shortage of donors and the long waiting lists, many of those patients are candidates for implantation of ventricular assist devices as a bridge to the cardiac transplant, or when this is not an option, as a definitive therapy.
View Article and Find Full Text PDFSuccessful treatment of near-fatal fulminant myocarditis using bi-ventricular assist device support.
J Artif Organs
September 2016
Department of Transplant Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565, Japan.
Fulminant myocarditis is a rare but fatal serious disease that may cause prolonged native cardiac dysfunction with multiorgan failure despite temporary mechanical circulatory support with percutaneous venoatrial extracorporeal membrane oxygenation (VA-ECMO) or intraaortic balloon pumping (IABP). A 26-year-old man with fulminant myocarditis developed life-threatening multiorgan failure after 8 days support by VA-ECMO and IABP. He was transferred to our institution with prolonged cardiac dysfunction on hospital day 8; massive pulmonary edema developed into severe pulmonary dysfunction.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!